These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8652248)

  • 1. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
    Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
    Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
    J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
    Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
    Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
    Vogelzang NJ; Torkelson JL; Kennedy BJ
    Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late toxicity after chemotherapy of malignant testicular tumors].
    Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
    Urologe A; 1998 Nov; 37(6):635-47. PubMed ID: 9887493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.
    Stefenelli T; Kuzmits R; Ulrich W; Glogar D
    Eur Heart J; 1988 May; 9(5):552-6. PubMed ID: 2456930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term complications of chemotherapy for germ cell tumours.
    Chaudhary UB; Haldas JR
    Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.
    Hansen SW; Olsen N; Rossing N; Rørth M
    Ann Oncol; 1990 Jul; 1(4):289-92. PubMed ID: 1702313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
    Kawai K; Hinotsu S; Tomobe M; Akaza H
    Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
    Hladunewich M; Sawka C; Fam A; Franssen E
    J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold.
    Hansen SW; Olsen N
    J Clin Oncol; 1989 Jul; 7(7):940-2. PubMed ID: 2472472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of metastatic seminoma by chemotherapy.: an experience].
    Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute anterior myocardial infarction after chemotherapy for testicular seminoma in a young patient.
    Ozben B; Kurt R; Oflaz H; Sezer M; Basaran M; Goren T; Umman S
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):439-42. PubMed ID: 17911198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular toxicity associated with chemotherapy for testicular cancer.
    Gerl A
    Anticancer Drugs; 1994 Dec; 5(6):607-14. PubMed ID: 7534146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.
    Atas E; Korkmazer N; Artik HA; Babacan O; Kesik V
    J Cancer Res Ther; 2015; 11(3):666. PubMed ID: 26458705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
    Scheulen ME; Schmidt CG
    Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
    Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
    Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.